However, Weber et al. reported a protective role for IL-22 in the BC mouse model as they observed that the treatment of EMT6 cells with IL-22 not only did not induce angiogenesis and apoptosis but also reduced tumor growth and promoted cell cycle arrest through the reduction of ERK1/2 and AKT phosphorylation [104]. This evidence concerns the gene AKT1 and breast cancer.